Spots Global Cancer Trial Database for Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
Official Title: A Multicentre, Open-label, Single-arm Study to Investigate the Efficacy and Safety of Triptorelin Pamoate 22.5 mg 6-month Formulation in Chinese Patients With Locally Advanced or Metastatic Prostate Cancer
Study ID: NCT05590793
Interventions
Study Description
Brief Summary: The main aim of this study is to assess the effectiveness and safety of the 6-month formulation of triptorelin pamoate in Chinese participants with locally advanced or metastatic cancer of the prostate. Participants will receive 1 injection of triptorelin pamoate 6-month formulation.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Affiliated Hospital of Hebei University, Baoding, , China
Beijing Hospital, Beijing, , China
Peking University First Hospital, Beijing, , China
Peking University People's Hospital, Beijing, , China
Hunan Cancer Hospital, Changsha, , China
West China Hospital of Sichuan University, Chengdu, , China
Chongqing University Cancer Hospital, Chongqing, , China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, , China
Deyang People's Hospital, Deyang, , China
Sun Yat-Sen University Cancer Center, Guangzhou, , China
Guizhou Provincial People's Hospital, Guiyang, , China
The Affiliated Hospital of Guizhou Medical University, Guiyang, , China
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, , China
Qilu Hospital of Shandong University, Jinan, , China
Shandong Provincial Hospital, Jinan, , China
Nanjing Drum Tower Hospital, Nanjing, , China
Zhongda Hospital Southeast University, Nanjing, , China
Ningbo First Hospital, Ningbo, , China
Fudan University Shang Hai Cancer Center, Shanghai, , China
Shanghai Fifth People's Hospital, Shanghai, , China
Shanghai Tongji Hospital, Shanghai, , China
Liaoning Cancer Hospital & Institute, Shenyang, , China
The First Hospital of China Medical University, Shenyang, , China
Peking University Shenzhen Hospital, Shenzhen, , China
Suining Central Hospital, Suining, , China
The Second Affiliated Hospital of Soochow University, Suzhou, , China
Tianjin Cancer Hospital, Tianjin, , China
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, , China
The First Affiliated Hospital of Wannan Medical College, Wuhu, , China
The Second Affiliated Hospital of Wannan Medical College, Wuhu, , China
Wuxi People's Hospital, Wuxi, , China
Northern Jiangsu People's Hospital, Yangzhou, , China
Subei People's Hospital, Yangzhou, , China
Yantai Yuhuangding Hospital, Yantai, , China
Henan Cancer Hospital, Zhengzhou, , China
Zigong First People's Hospital, Zigong, , China
Contact Details
Name: Ipsen Medical, Director
Affiliation: Ipsen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
